Regional Monitoring EECA
by ECUO PLWH
Showing 1-7 of 7 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
2Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps6.496-30194.88--National Health Service (NHC)2016Not specifiedNot specifiedNot specified
3Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
4Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
5Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.26241803036208067490162016YesYesNot specified
6Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.442015Not specifiedNot specifiedNot specified
7Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified